失调的miR-133a通过直接靶向人类椎间盘退变中的基质金属蛋白酶9(MMP9)介导II型胶原蛋白的缺失。
Dysregulated miR-133a Mediates Loss of Type II Collagen by Directly Targeting Matrix Metalloproteinase 9 (MMP9) in Human Intervertebral Disc Degeneration.
作者信息
Xu Yun-Qiang, Zhang Zhen-Hui, Zheng Yong-Fa, Feng Shi-Qing
机构信息
Department of Orthopedic Surgery, Tianjin Medical University General Hospital, Tianjin, China.
出版信息
Spine (Phila Pa 1976). 2016 Jun;41(12):E717-E724. doi: 10.1097/BRS.0000000000001375.
STUDY DESIGN
A microRNA (miRNA) study using Solexa sequencing.
OBJECTIVE
The purpose of this study was to identify intervertebral disc degeneration (IDD)-specific miRNA expression profile, and to validate its biological function.
SUMMARY OF BACKGROUND DATA
Accumulating evidence indicates that miRNAs play a critical role in IDD, but the role of specific miRNAs involved in this entity remains unclear.
METHODS
MiRNA expression profile was determined in nucleus pulposus (NP) tissues from patients with IDD and controls, employing Solexa sequencing and quantitative real-time PCR (qRT-PCR). Biological functions of differential expression miRNAs were further investigated. Luciferase reporter assays and western blotting were performed to determine miRNA targets.
RESULTS
We identified 31 miRNAs that were differentially expressed (22 upregulated and nine downregulated) in patients compared with controls. After qRT-PCR confirmation, miR-133a was significantly down-regulated in degenerative NP tissues. Moreover, its level was inversely correlated with grade of disc degeneration. Through gain- and loss-of-function studies, miR-133a was demonstrated to significantly promote type II collagen expression in NP cells. MMP9 was identified as a target of miR-133a. Knockdown of MMP9 induced effects on NP cells similar to those induced by miR-133a. Expression of MMP9 was inversely correlated with miR-133a expression in degenerative NP tissues.
CONCLUSION
These results suggest that the downregulation of miR-133a induces type II collagen loss by directly targeting MMP9. Our findings also highlight miR-133a as a novel hopeful therapeutic target for IDD.
LEVEL OF EVIDENCE
研究设计
一项使用Solexa测序的微小RNA(miRNA)研究。
目的
本研究旨在鉴定椎间盘退变(IDD)特异性miRNA表达谱,并验证其生物学功能。
背景资料总结
越来越多的证据表明,miRNA在IDD中起关键作用,但参与该疾病的特定miRNA的作用仍不清楚。
方法
采用Solexa测序和定量实时PCR(qRT-PCR)技术,测定IDD患者和对照组髓核(NP)组织中的miRNA表达谱。进一步研究差异表达miRNA的生物学功能。进行荧光素酶报告基因检测和蛋白质印迹分析以确定miRNA靶点。
结果
与对照组相比,我们在患者中鉴定出31种差异表达的miRNA(22种上调,9种下调)。经qRT-PCR确认后,miR-133a在退变的NP组织中显著下调。此外,其水平与椎间盘退变程度呈负相关。通过功能获得和功能缺失研究,证明miR-133a能显著促进NP细胞中II型胶原蛋白的表达。MMP9被鉴定为miR-133a的靶点。敲低MMP9对NP细胞的影响与miR-133a诱导的影响相似。在退变的NP组织中,MMP9的表达与miR-133a的表达呈负相关。
结论
这些结果表明,miR-133a的下调通过直接靶向MMP9导致II型胶原蛋白丢失。我们的研究结果还突出了miR-133a作为IDD一种新的有希望的治疗靶点。
证据水平
3级。